Jagsonpal Pharmaceuticals allotted 176,900 equity shares to employees under its ESOP 2022 plan on April 13, 2026.
The company's paid-up share capital increased from ₹13.39 crore to ₹13.43 crore following the allotment.
The newly issued shares rank pari-passu with existing equity shares and were exercised at varying prices between ₹94.00 and ₹115.60.
This is a regulatory disclosure filed pursuant to SEBI LODR and Share Based Employee Benefits Regulations.